Ads
related to: mymta beta blocker
Search results
Results from the Go Local Guru Content Network
Puberty blocker. Puberty blockers (also called puberty inhibitors or hormone blockers) are medicines used to postpone puberty in children. The most commonly used puberty blockers are gonadotropin-releasing hormone (GnRH) agonists, which suppress the natural production of sex hormones, such as androgens (e.g. testosterone) and estrogens (e.g ...
3 β 2 blockers. 1 comment. 4 Anon question. 2 comments. 5 Cleanup needed. 3 comments ...
Adverse effects. Over 10% of oral sotalol users experience fatigue, dizziness, lightheadedness, headache, weakness, nausea, shortness of breath, bradycardia (slow heart rate), a sensation of the heart beating too hard, fast, or irregularly, or chest pain. Higher doses of sotalol increase the risk for all of these possible side effects.
Beta blocker; This page is a redirect. The following categories are used to track and monitor this redirect: From the plural form: This is a redirect from a plural ...
Linemen blocking for the running back. In American football, blocking or interference (or running interference) involves legal movements in which one player uses his body to obstruct another player's path. The purpose of blocking is to prevent defensive players from tackling the ball carrier, or to protect a quarterback who is attempting to ...
Adrenergic blocking agent. Adrenergic blocking agents are a class of drugs that exhibit its pharmacological action through inhibiting the action of the sympathetic nervous system [1] in the body. The sympathetic nervous system (SNS) is an autonomic nervous system that we cannot control by will.
Alpha-1 blocker. Alpha-1 blockers (also called alpha-adrenergic blocking agents or alpha-1 antagonists) constitute a variety of drugs that block the effect of catecholamines on alpha-1-adrenergic receptors. They are mainly used to treat benign prostatic hyperplasia (BPH), hypertension and post-traumatic stress disorder. [1]
Celiprolol. Celiprolol is a medication in the class of beta blockers, used in the treatment of high blood pressure. It has a unique pharmacology: it is a selective β1 receptor antagonist, but a β2 receptor partial agonist. It is also a weak α2 receptor antagonist. It was patented in 1973 and approved for medical use in 1982.